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Background:  Early, late, and very late stent thrombosis (ST) may differ in clinical presentation, management, and in-hospital outcomes.
Methods:  We analyzed patients presenting with definite (angiographically-documented) ST identified from 02/2009-03/2010 in the National 
Cardiovascular Data CathPCI Registry®. ST events were subdivided by timing of presentation: early (<1 month), late (1-12 months) or very late (>12 
months) following PCI. Multivariable logistic regression modeling was performed to evaluate if in-hospital mortality was associated with each type of 
ST after adjusting for baseline comorbidities.
Results:  During the study period, 5,477 ST events occurred in 5,319 pts (1.84%) out of 289,018 pts presenting with ACS. The population consisted of 
1,012 early ST (19%), 1,076 late ST (20%), and 3,231 very late ST (61%). Subjects differed in baseline characteristics and treatment based on timing 
of ST (Table). Success of lesion treatment was higher in late (91%) and very late (92%) ST than in early ST (88%, p=0.002). In-hospital mortality was 
lower in patients with late (3.1%) and very late ST (3.6%) than in early ST (8.1%, p<0.001). This lower mortality persisted after multivariable adjustment; 
compared with early ST, adjusted OR for late ST was 0.48 [95% CI 0.30-0.78] and 0.55 [95% CI 0.39-0.77] for very late ST.
Conclusions:  Very late ST occurs more frequently compared with early or late ST in this registry. Early ST is associated with higher in-hospital 
mortality compared with late or very late ST. 
Variable
Early
(<1 month)
(N=1,012)
Late
(1-12 months)
(N=1,076)
Very Late
(>12 months)
(N=3,231)
P-value
Age, years 62 +/- 12.3 60 +/- 13.3 61 +/- 12 0.0355
Male (%) 689 (68) 764 (71) 2463 (76) <0.001
White (%) 834 (82.4) 916 (85.1) 2900 (89.8) <0.0001
Diabetes (%) 436 (43.1) 401 (37.3) 898 (27.8) <0.0001
Prior CHF (%) 180 (17.8) 161 (15.0) 367 (11.3) <0.0001
Symptoms on admission (with ST)
Unstable angina (%) 111 (11.0) 281 (26.1) 419 (12.9) <0.0001
NSTEMI (%) 231 (22.8) 277 (25.7) 689 (21.3) <0.0001
STEMI (%) 670 (66.2) 518 (48.1) 2123 (65.7) <0.0001
Cardiogenic Shock (%) 137 (13.5) 94 (8.7) 276 (8.5) <0.0001
Prior DES stent (%) 604 (59.7) 616 (57.3) 1811 (56.0) <0.0001
Thrombectomy (%) 316 (31.2) 287 (26.7) 1070 (33.1) 0.0004
New stent placed
DES (%) 274 (27.1) 394 (36.6) 1546 (47.9) <0.0001
BMS (%) 242 (23.9) 208 (19.3) 717 (22.2) <0.0001
Lesion success (%) 890 (87.9) 974 (90.5) 2960 (91.6) 0.0021
In-hospital mortality (%) 82 (8.1) 33 (3.1) 116 (3.6) <0.0001
